KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Global Medical REIT (GMRE) over the last 10 years, with Q3 2025 value amounting to -$6.0 million.

  • Global Medical REIT's Net Income towards Common Stockholders fell 43506.42% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year decrease of 13701.85%. This contributed to the annual value of $811000.0 for FY2024, which is 9451.66% down from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's Net Income towards Common Stockholders is -$6.0 million, which was down 43506.42% from -$800000.0 recorded in Q2 2025.
  • Global Medical REIT's 5-year Net Income towards Common Stockholders high stood at $11.8 million for Q2 2023, and its period low was -$6.0 million during Q3 2025.
  • For the 5-year period, Global Medical REIT's Net Income towards Common Stockholders averaged around $1.9 million, with its median value being $1.8 million (2024).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 115147.06% in 2021, then plummeted by 43506.42% in 2025.
  • Over the past 5 years, Global Medical REIT's Net Income towards Common Stockholders (Quarter) stood at $3.8 million in 2021, then tumbled by 90.32% to $368000.0 in 2022, then crashed by 328.26% to -$840000.0 in 2023, then skyrocketed by 263.57% to $1.4 million in 2024, then plummeted by 536.75% to -$6.0 million in 2025.
  • Its last three reported values are -$6.0 million in Q3 2025, -$800000.0 for Q2 2025, and $2.1 million during Q1 2025.